Pancreatic Cancer Research

ResearcherSheng Jing HospitalNo recent work listed

Xiaodong Chen

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
5 (first author 3, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2014: 3 papers · 2015: 2 papers

Papers 5

  1. Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer. Last author DOI 10.1007/s00261-015-0544-3↗
  2. Serum ferritin predicted prognosis in patients with locally advanced pancreatic cancer. Last author DOI 10.2217/fon.15.186↗
  3. Quantitative assessment of the diagnostic role of human telomerase activity from pancreatic juice in pancreatic cancer. First author DOI 10.1007/s13277-014-2053-3↗
  4. Quantitative assessment of the diagnostic role of MUC1 in pancreatic ductal adenocarcinoma. First author DOI 10.1007/s13277-014-2186-4↗
  5. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2. First author DOI 10.3892/or.2014.3478↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Meiyue Tang · 5 shared papers, 2014–2015 · strength 0.32
  2. Siliang Wang · 3 shared papers, 2014 · strength 0.21
  3. Si-Liang Wang · 2 shared papers, 2015 · strength 0.11
  4. Yunan Sun · 1 shared paper, 2015 · strength 0.05
  5. Rong Wu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.